updated 6/1/2011 7:16:33 AM ET 2011-06-01T11:16:33

DALLAS, June 1, 2011 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring MultiCell Technologies Inc. (OTCBB:MCET). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

The full report is available at: www.microstockprofit.com/lp/MCET

MultiCell Technologies Inc. (MCET) is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer.

This newsletter has been helping traders make great investment decisions on MCET; click here for a 25% discount offer.

In the report, the analyst notes:

"Shares of MCET rocketed more than 356% in yesterday's trading on news that the company was awarded a patent relating to the isolation and use of human liver stem cells to treat liver disease. The Rhode Island-based biopharmaceutical firm has signed an agreement with Rhode Island Hospital to be the worldwide licensee of U.S. patent 7,935,528."

"MCET chairman and CEO W. Gerald Newmin said the Company is pleased that the U.S. Patent and Trademark Office has agreed that its liver stem cells are indeed novel and may lead to important therapeutic applications."

To read the entire report visit: www.microstockprofit.com/lp/MCET

See what investors are saying about MCET at http://www.stockhideout.com

Get breaking news on MCET at http://thestockmarketwatch.com/

MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on MicroStockProfit please visit: http://www.microstockprofit.com

MicroStockProfit.com Disclosure

MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.

CONTACT: Brian Johnson
         info@microstockprofit.com
         1-888-307-2850

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 4.95%
$30K home equity loan FICO 5.19%
$75K home equity loan FICO 4.58%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.40%
13.40%
Cash Back Cards 17.92%
17.91%
Rewards Cards 17.12%
17.11%
Source: Bankrate.com